The top news stories from Latin America

Provided by AGP

Got News to Share?

Latin American Newswire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin American Newswire.

Press releases published on April 17, 2026

ASTROIDEAL  El servicio mejor valorado por usuarios en España
CAMP BY THE LOREN, A LIMITED-TIME, CULINARY EXPERIENCE IS NOW OPEN AT THE LOREN AT TURTLE COVE RESIDENCES AND HOTEL
Apartment Realty Group (ARG) Sells 6-Unit Trophy Asset in Coastal Carlsbad
XM y la narrativa de transparencia, consistencia y estructura en el trading minorista
Phytase Enzyme for Animal-Free Brewing Application Market Set for Growth Led by BASF, Novozymes, DSM-Firmenich, AB Vista
Sanford Housing Authority Partners with sigma‑Cogent Solutions to Complete HR Audit and Workforce Modernization
Unstoppable is a New Mantra for Business Leaders
Global Active Insulation Market: Mexico 6.5% CAGR Growth Led by Polartec, PrimaLoft, and 3M
Landmark Lancet Study Demonstrates Safety and Efficacy of Magnetic Seizure Therapy in Depression
Grupo Aeroportuario del Pacifico Announces Filing of 2025 Annual Report and Form 20-F
Global Propylene Glycol Market: Brazil Drives Latin America Growth with Dow, BASF, ADM Leading
Global Agricultural Film Market Led by North America; Mexico Growth Driven by Berry Global, BASF, Novamont
AGM Mobile presentará sus últimas innovaciones robustas en la Feria de Cantón 2026
5 Key Advantages of Partnering with a China Leading Bottom Cover Tape Supplier for Global Electronics
Boundless Bio Presents Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules
CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026
Revolution Medicines Announces Closing of Concurrent Upsized Public Offerings with Aggregate Gross Proceeds of Approximately $2.2 Billion, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Share us

on your social networks:

Sign up for:

Latin American Newswire

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.